TITLE:
Impact of Biological Monitoring of HIV-Positive Pregnant Women on the Serological Status of Infants: The Case of the Lualaba Provincial Health Division
AUTHORS:
Aimé Kasongo Kayembe, Francis Kambol Yav, Henry Tshibamb Mutomb, Eddy Masela Kakese, Cathyna Kayemb Kapend, Terence Lubala Ngandu, Alice Musehenu Kambol, Françoise Malonga Kaj
KEYWORDS:
Biological Monitoring, HIV, Infants, Serological Status
JOURNAL NAME:
Health,
Vol.18 No.11,
November
20,
2026
ABSTRACT: Introduction: Pediatric HIV infection emerged in our region in 1997, when the first HIV-infected child was reported in the Lualaba referral zone. Our study aims to determine the impact of biological monitoring of HIV-positive pregnant women on the serological status of their infants in 2023. Method: We conducted a descriptive cross-sectional study with retrospective data collection. We utilized the validated 2023 PNLS BPC Lualaba database. Data collection was exhaustive. Information regarding 484 HIV-positive pregnant women was analyzed. Serological testing of the children and mothers was performed using GeneXpert as well as Western Blot. Results: In 2023, 321,868 pregnant women were registered at various prenatal care (PNC) clinics under the Lualaba Provincial Health Division (DPS). Of these, 48,655 received HIV counseling and testing, with 484 testing positive—results confirmed via GeenExpert. This yielded an overall seroprevalence of 1.0%. There were 372 infants born to HIV-positive mothers; 301 of them were immediately placed on antiretroviral therapy, representing a pediatric coverage rate of 81.7%. Among the 372 infants born to HIV-positive mothers, 17 tested positive for HIV between 4 and 6 weeks of age, resulting in a recorded mother-to-child transmission rate of 4.6% which is the result of 17 children born and testing positive for HIV out of the 372 HIV-positive mothers followed in this study. The highest rate of pediatric transmission was recorded in the Mutshatsha Health Zone (35.3%), followed by Bunkeya (11.1%), and then Dilolo and Fungurume (5.0% each). Among the 301 children born to mothers receiving antiretrovirals and achieving viral load suppression, 17 children was tested positive for HIV at 6 weeks. Only one was born to a mother with an undetectable viral load (1.5%) against (6.8%) who born to a mother with a detectable viral load. Pregnant women in health zones with less than 50% PMTCT coverage (HIV-positive pregnant women placed on antiretrovirals) faced an estimated risk of HIV transmission to their children (OR = 4.95 [1.8; 13.4]). This risk is statistically significant. Compared to HIV-positive pregnant women who started antiretroviral (ARV) treatment before the pregnancy, those who started ARV treatment during the pregnancy faced an estimated risk of HIV transmission to their children (OR = 3.2053 [1.1058; 9.2911]). This risk is statistically significant. Regarding the treatment regimens, all children born to HIV-positive mothers had been placed on the same treatment regimen. Conclusion: Our study demonstrated that rigorous biological monitoring of HIV-positive pregnant women had a direct, beneficial impact on the serological status of infants born to HIV-positive mothers. It helped reduce vertical HIV transmission, improve infection management for both mothers and children, and ensure better health for future generations. The government must increase its involvement in implementing this activity throughout the provincial division in order to save lives.